<?xml version="1.0" encoding="UTF-8"?>
<p>The MIC of compound 
 <bold>395</bold> against 
 <italic>Staphylococcus aureus</italic> (MSSA), Methicillin resistant 
 <italic>Staphylococcus aureus</italic> (MRSA) and 
 <italic>Klebsiella pneumoniae carbapenemase-producing</italic> (KPC) was performed. Vochysiamide B 
 <bold>395</bold> displayed considerable antibacterial activity against the Gram-negative bacterium 
 <italic>Klebsiella pneumoniae</italic> (KPC), a producer of carbapenemases, MIC of 80 μg/mL in comparison with positive controls meropenem and gentamicin with MIC values of 45 μg/mL and 410 μg/mL against KPC [
 <xref rid="B129-ijms-22-00959" ref-type="bibr">129</xref>].
</p>
